Board Meetings for MANGALAM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
MANGALAMMangalam Drugs And Organics Limited04 Aug 2017Results/Othersinter-alia to consider and approve the following: (1) To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter ended June 30, 2017 2. Any other matters with the permission of the chair.
MANGALAMMangalam Drugs And Organics Limited08 May 2017Results/Othersinter-alia to consider, approve and take on record the Audited Financial Results/Statement of the company for the quarter and year ended March 31, 2017 and any other matters with the permission of the Chair. Further the Trading Window for the purpose of the said Board Meeting will remain closed from April 29, 2017 and would open 48 hours after the announcement of financial results to the public.
MANGALAMMangalam Drugs And Organics Limited06 Feb 2017Results/Othersinter-alia to consider and approve the following:1) To approve, consider and take on record the Unaudited Financial Results of the company for the quarter and nine months ended December 31, 20162) Any other matters with the permission of the chair.
MANGALAMMangalam Drugs And Organics Limited10 Nov 2016Results/Othersinter-alia to consider and approve the following: 1)To approve, consider and take on record the Unaudited Financial Results of the company for the quarter and half year ended 30th September, 2016 2) Any other matters with the permission of the chair. Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for all directors, officers and designated employees of the Company from November 02, 2016 and would open 48 hours after the announcement of financial results to the public.
MANGALAMMangalam Drugs And Organics Limited01 Aug 2016Results/Othersinter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results of the company for the quarter ended June 30, 2016 2. Any other matters with the permission of the chair.
MANGALAMMangalam Drugs And Organics Limited10 Jun 2016Board Meeting PostponedMANGALAM : 10-Jun-2016 : The Company had informed the Exchange regarding the Board Meeting to be held on June 06, 2016 to inter alia consider and approve the allotment of 14,50,000 Equity Shares on conversion of remaining 14,50,000 Share Warrants which were allotted on preferential basis to Shri JB Pharma LLP, ( Promoter or Proposed Allottee ) on September 28, 2015 and the issue of which was approved by the shareholders at Annual General Meeting of the Company held on September 3, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations. The company has now inform the exchange that due to unavoidable circumstances the meeting of Board of Directors is postponed and re-scheduled to June 10, 2016.
MANGALAMMangalam Drugs And Organics Limited06 Jun 2016OthersTo inter alia consider and approve the allotment of 14,50,000 Equity Shares on conversion of remaining 14,50,000 Share Warrants which were allotted on preferential basis to Shri JB Pharma LLP, ( Promoter or Proposed Allottee ) on September 28, 2015 and the issue of which was approved by the shareholders at Annual General Meeting of the Company held on September 3, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations.
MANGALAMMangalam Drugs And Organics Limited16 May 2016Results/OthersInter-alia to consider, approve and take on record the following:1. To consider and take on record the Audited Financial Results for the quarter and year ended March 31, 20162. Any other matters with the permission of the chair
MANGALAMMangalam Drugs And Organics Limited14 Jan 2016Results/Othersinter alia to consider and take on record the following : (1) . To consider and take on record the Unaudited Financial Results for the quarter and nine months ended December 31, 2015 (2).To appoint the Internal Auditor of the company for the financial year 2015-2016;(3) To appoint the Secretarial Auditor of the company for the financial year 2015-16.(4).Any other matters with the permission of the chair.
MANGALAMMangalam Drugs And Organics Limited16 Nov 2015OthersTo inter alia consider and approve the allotment of 12,00,000 Equity Shares on conversion of 12,00,000 Share Warrants which were allotted on preferential basis to Shri.JB Pharma LLP, ("Promoter" or "Proposed Allottee") on September 28, 2015 and the issue of which was approved by the shareholders at 42nd Annual General Meeting of the Company held on September 3, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations.
MANGALAMMangalam Drugs And Organics Limited21 Oct 2015Results/Othersinter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2015 and any other matter with the permission ofthe chair.
MANGALAMMangalam Drugs And Organics Limited06 Aug 2015Issue of SecuritiesTo inter alia consider and approve the issue of such number of Warrants or other securities convertible into equity shares or other securities convertible into equity shares on preferential basis to Shri.JB Pharma LLP, ( Promoter or Proposed Allottee ) subject to the approval of the Members, in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations.
MANGALAMMangalam Drugs And Organics Limited04 Aug 2015ResultsInter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2015.
MANGALAMMangalam Drugs And Organics Limited15 May 2015ResultsTo consider annual audited financial results for the year ended on March 31, 2015.
-
MANGALAMMangalam Drugs And Organics Limited23 Jan 2015ResultsInter-alia to consider and take on record Unaudited Financial results for the Quater ended December 31,2014.
-
Showing page 5 of 8 (116 total items)